The 11th edition of the International cGMP Conference was once again a central meeting place for researchers from the fields of biology, pharmacology, and medicine. As the official meeting report in the Naunyn-Schmiedeberg Archives of Pharmacology shows, the conference provided a comprehensive overview of current developments in the field of cGMP signaling—from molecular fundamentals to clinical applications.
Particular emphasis was placed on the role of cGMP in cardiovascular, pulmonary, and renal diseases, as well as on applications in rare diseases and urological indications. New therapeutic strategies were discussed, including those based on sGC stimulators and activators that have already found their way into clinical practice or are currently being investigated.
In addition to the scientific presentations, the conference offered numerous opportunities for exchange between established experts and young researchers. Poster sessions, discussion panels, and interdisciplinary contributions highlighted the diversity of the research field and the importance of networking for new ideas.
The conference impressively demonstrated how closely basic research and clinical development are linked. Findings from signal transduction and molecular pharmacology can be directly translated into new approaches for treating serious diseases—a prime example of successful translational research.
The conference impressively demonstrated how closely basic research and clinical development are intertwined. Insights from signal transduction and molecular pharmacology can be directly translated into new approaches for treating severe diseases – a prime example of successful translational research.
FEBGLA e.V. looks back with pride on the successful meeting and is delighted to be part of this active scientific community. The focus is already turning to the future: the 12th International cGMP Conference will take place in Kassel from June 18 to 20, 2026.
Further information can be found in the detailed meeting report available here as an open-access article: Springer-Link.